3-BROMO-2-METHYLPROPYL ACETATE, 95.0%, 1g

(3,5-dimethyl-1H-pyrazol-4-yl)acetic acid, 95.0%, 1g

1-(1-Methyl-1H-benzo[d]imidazol-2-yl)ethan-1-ol, 98%, 100mg

DMT-2'-O-methyl-rC(Ac) Phosphoramidite>95.0%(qNMR)250mg

2,2-Dichloroacetaldehyde hydrate, 90.0%, 5g

(Z)-Methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate (Nintedanib Impurity), 97%, 50mg

3-Methylfuran (stabilised with Hydroquinone), 98.0%, 1g

Silver foil 99.995% 1.0 x 50 x 50 mm 1 pc

Silver wire 99.9% 2.5 mm diameter 2,5 m

tert-Butyl [(1-cyclohexylpiperidin-4-yl)methyl]carbamate, 95.0%, 1g

(4R,12aS)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxylic acid, 1g

4-Amino-5-bromo-2-chloropyridine, 95.0%, 10g

4-[3-(trifluoromethyl)-1h-pyrazol-1-yl]aniline, 97%, 1g